[1] Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA. Cerebral amyloid angiopathy related inflammation:three case reports and a review[J]. J Neurol Neurosurg Psychiatry, 2011, 82:20-26.
[2] Auriel E, Charidimou A, Gurol ME, Ni J, Van Etten ES, Martinez-Ramirez S, Boulouis G, Piazza F, Di Francesco JC, Frosch MP, Pontes-Neto OV, Shoamanesh A, Reijmer Y, Vashkevich A, Ayres AM, Schwab KM, Viswanathan A, Greenberg SM. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation[J]. JAMA Neurol, 2016, 73:197-202.
[3] Danve A, Grafe M, Deodhar A. Amyloid beta-related angiitis:a case report and comprehensive review of literature of 94 cases[J]. Semin Arthritis Rheum, 2014, 44:86-92.
[4] Regenhardt RW, Thon JM, Das AS, Thon OR, Charidimou A, Viswanathan A, Gurol ME, Chwalisz BK, Frosch MP, Cho TA, Greenberg SM. Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation[J]. JAMA Neurol, 2020, 22:e201782.
[5] Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, Jouanny P, Dubois B, Eisner L, Flitman S, Michel BF, Boada M, Frank A, Hock C. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization[J]. Neurology, 2003, 61:46-54.
[6] Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman M. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab:a retrospective analysis[J]. Lancet Neurol, 2012, 11:241-249.
[7] DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, Galimberti G, Conti E, Curtò NA, Marzorati L, Remida P, Tagliavini F, Savoiardo M, Ferrarese C. Anti-abeta autoantibodies in the csf of a patient with caa-related inflammation:a case report[J]. Neurology, 2011, 76:842-844.
[8] Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, Nitrini R, Sakaguchi H, Brioschi M, Billo G, Colombo A, Lanzani F, Piscosquito G, Carriero MR, Giaccone G, Tagliavini F, Ferrarese C, DiFrancesco JC. Anti-amyloid beta autoantibodies in cerebral amyloid angiopathy-related inflammation:implications for amyloid-modifying therapies[J]. Ann Neurol, 2013, 73:449-458.
[9] Miao J, Vitek MP, Xu F, Previti ML, Davis J, Van Nostrand WE. Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice[J]. J Neurosci, 2005, 25:6271-6277.
[10] Vromman A, Trabelsi N, Rouxel C, Béréziat G, Limon I, Blaise R. β-amyloid context intensifies vascular smooth muscle cells induced inflammatory response and de-differentiation[J]. Aging Cell, 2013, 12:358-369.
[11] Salvarani C, Brown Jr RD, Calamia KT, Christianson TJ, Huston 3rd J, Meschia JF, Giannini C, Miller DV, Hunder GG. Primary central nervous system vasculitis:comparison of patients with and without cerebral amyloid angiopathy[J]. Rheumatology (Oxford), 2008, 47:1671-1677.
[12] Melzer N, Harder A, Gross CC, W ölfer J, Stummer W, Niederstadt T, Meuth SG, Marziniak M, Grauer OM, Wiendl H. CD4(+) T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid beta-related angiitis[J]. Arch Neurol, 2012, 69:773-777.
[13] Xu YY, Chen S, Zhao JH, Chen XL, Zhang JW. A case of cerebral amyloid angiopathy-related inflammation with the rare apolipoprotein epsilon2/epsilon2 genotype[J]. Front Neurol, 2019, 10:547.
[14] Salvarani C, Hunder GG, Morris JM, Brown Jr RD, Christianson T, Giannini C. A β-related angiitis:comparison with CAA without inflammation and primary CNS vasculitis[J]. Neurology, 2013, 81:1596-1603.
[15] Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, Greenberg SM. Course of cerebral amyloid angiopathy-related inflammation[J]. Neurology, 2007, 68:1411-1416.
[16] Renard D, Tatu L, Collombier L, Wacongne A, Ayrignac X, Charif M, Boukriche Y, Chiper L, Fourcade G, Azakri S, Gaillard N, Mercier E, Lehmann S, Thouvenot E. Cerebral amyloid angiopathy and cerebral amyloid angiopathy-related inflammation:comparison of hemorrhagic and DWI MRI features[J]. J Alzheimers Dis, 2018, 64:1113-1121.
[17] Du Y, Liu C, Ma C, Xu X, Zhou X, Zhou H, Huang C. Cerebral amyloid angiopathy-related inflammation:a case report presenting with a rare variant in SORL1 gene[J]. BMC Neurol, 2019, 19:97.
[18] Chamard L, Wallon D, Pijoff A, Berger E, Viennet G, Hannequin D, Magnin E. Amyloid-related imaging abnormalities in AβPP duplication carriers[J]. J Alzheimers Dis, 2013, 37:789-793.
[19] Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation[J]. Ann Neurol, 2004, 55:250-256.
[20] Sakai K, Hayashi S, Sanpei K, Yamada M, Takahashi H. Multiple cerebral infarcts with a few vasculitic lesions in the chronic stage of cerebral amyloid angiopathy-related inflammation[J]. Neuropathology, 2012, 32:551-556.
[21] Salvarani C, Morris JM, Giannini C, Brown Jr RD, Christianson T, Hunder GG. Imaging findings of cerebral amyloid angiopathy, abeta-related angiitis (ABRA), and cerebral amyloid angiopathy-related inflammation:a single-institution 25-year experience[J]. Medicine (Baltimore), 2016, 95:e3613.
[22] Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S. Abeta-related angiitis:primary angiitis of the central nervous system associated with cerebral amyloid angiopathy[J]. Brain, 2005, 128:500-515.
[23] Corovic A, Kelly S, Markus HS. Cerebral amyloid angiopathy associated with inflammation:a systematic review of clinical and imaging features and outcome[J]. Int J Stroke, 2018, 13:257-267.
[24] Chu S, Xu F, Su Y, Chen H, Cheng X. Cerebral amyloid angiopathy (CAA)-related inflammation:comparison of inflammatory CAA and amyloid-β-related angiitis[J]. J Alzheimers Dis, 2016, 51:525-532.
[25] Renard D, Wacongne A, Ayrignac X, Charif M, Fourcade G, Azakri S, Floch AL, Bouly S, Marelli C, Arquizan C, Hirtz C, Gabelle A, Thouvenot E, Lehmann S. Cerebrospinal fluid Alzheimer's disease biomarkers in cerebral amyloid angiopathy-related inflammation[J]. J Alzheimers Dis, 2016, 50:759-764.
[26] Kimura A, Takemura M, Saito K, Yoshikura N, Hayashi Y, Harada N, Nishida H, Nakajima H, Inuzuka T. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation[J]. J Neurol, 2017, 264:373-381.
[27] Carmona-Iragui M, Fernández-Arcos A, Alcolea D, Piazza F, Morenas-Rodriguez E, Antón-Aguirre S, Sala I, Clarimon J, Dols-Icardo O, Camacho V, Sampedro F, Munuera J, Nuñez-Marin F, Lleó A, Fortea J, Gómez-Ansón B, Blesa R. Cerebrospinal fluid anti-amyloid-beta autoantibodies and amyloid PET in cerebral amyloid angiopathy-related inflammation[J]. J Alzheimers Dis, 2016, 50:1-7.
[28] Martucci M, Sarria S, Toledo M, Coscojuela P, Vert C, Siurana S, Auger C, Rovira A. Cerebral amyloid angiopathy-related inflammation:imaging findings and clinical outcome[J]. Neuroradiology, 2014, 56:283-289.
[29] Renard D, Wacongne A, Le Floch A, Thouvenot E. Vicinity of FLAIR hyperintensities and SWI microbleeds in cerebral amyloid angiopathy-related inflammation[J]. Eur Neurol, 2016, 75:223-224.
[30] Renard D, Collombier L, Demattei C, Wacongne A, Charif M, Ayrignac X, Azakri S, Gaillard N, Boudousq V, Lehmann S, de Champfleur NM, Thouvenot E. Cerebrospinal fluid, MRI, and florbetaben-PET in cerebral amyloid angiopathy-related inflammation[J]. J Alzheimers Dis, 2018, 61:1107-1117.
[31] Coulette S, Renard D, Lehmann S, Raposo N, Arquizan C, Charif M, Thouvenot E, Wacongne A, Viguier A, Bonneville F, Allou T, Boukriche Y, Chiper L, Fourcade GB, Gabelle A, Ducros A, Duflos C, Labauge P, de Champfleur NM, Ayrignac X. A clinico-radiological study of cerebral amyloid angiopathy-related inflammation[J]. Cerebrovasc Dis, 2019, 48:38-44.
[32] Tetsuka S, Hashimoto R. Slightly symptomatic cerebral amyloid angiopathy-related inflammation with spontaneous remission in four months[J]. Case Rep Neurol Med, 2019:ID5308208.
[33] Caldas AC, Silva C, Albuquerque L, Pimentel J, Silva V, Ferro JM. Cerebral amyloid angiopathy associated with inflammation:report of 3 cases and systematic review[J]. J Stroke Cerebrovasc Dis, 2015, 24:2039-2048.
[34] Liang JW, Zhang W, Sarlin J, Boniece I. Case of cerebral amyloid angiopathy-related inflammation:is the absence of cerebral microbleeds a good prognostic sign[J]? J Stroke Cerebrovasc Dis, 2015, 24:e319-322.
[35] Sakaguchi H, Ueda A, Kosaka T, Yamashita S, Kimura E, Yamashita T, Maeda Y, Hirano T, Uchino M. Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction:case report and review of the literature[J]. J Neuroinflammation, 2011, 8:116. |